Objectives: To determine the mechanism of alcoholic liver disease so that dietary interventions and preventive medicine will make it possible to minimize this disease.
Specific Aims : To produce alcoholic liver disease which closely resembles human ALD including fatty change, inflammation, necrosis, and fibrosis of the liver in rats fed defined diets and alcohol by continuous intragastric feeding. This dietary regimen is modified in a way that by changing only one dietary ingredient, i.e. fat, no ALD lesion develops when the rats are fed ethanol. The diet which produces ALD contains 25% of calories derived from corn oil. The diet which prevents ALD substitutes corn oil with tallow (25% of calories). Using these two diet regimens, the one that produces ALD and the one that does not, the rats will be analyzed for the presence of biochemical and morphologic abnormalities in order to identify which abnormalities are associated with ALD and which are not. The abnormalities associated with ALD will be considered suspect as involved in the mechanism of ALD and will be studied further. Preventive measures will be tested to determine which mechanisms are involved by therapeutic intervention. Mechanisms to be studied include: 1) energy metabolism of the liver using 31P MRS in vivo correlated with 02 tension in the liver during chronic alcohol feeding; 2) linoleic acid/arachidonic acid metabolism using GL chromatography and HPLC of metabolites and inhibitors of arachidonate metabolizing enzymes; 3) morphometric determination of Ito cell activation associated with liver fibrosis using the electron microscope; 4) succinic dehydrogenase histochemistry for alcohol-induced increased permeability in zone 3 liver cells; and 5) vitamin A metabolism in ALD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA008116-04
Application #
2044283
Study Section
Special Emphasis Panel (SRCA (53))
Project Start
1990-11-01
Project End
1994-11-30
Budget Start
1992-07-01
Budget End
1994-11-30
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
City
Torrance
State
CA
Country
United States
Zip Code
90502
Tippin, Brigette L; Kwong, Alan M; Inadomi, Michael J et al. (2014) Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR. Cancer Med 3:1041-51
Le, Mary D; Enbom, Elena; Traum, Peter K et al. (2013) Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies. Exp Mol Pathol 95:187-91
Khachatoorian, Ronik; Dawson, David; Maloney, Eden M et al. (2013) SAMe treatment prevents the ethanol-induced epigenetic alterations of genes in the Toll-like receptor pathway. Exp Mol Pathol 94:243-6
French, B A; Oliva, J; Bardag-Gorce, F et al. (2012) Mallory-Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cells. Exp Mol Pathol 92:318-26
Oliva, Joan; French, Samuel W; Li, Jun et al. (2012) Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Exp Mol Pathol 93:26-34
Oliva, Joan; Zhong, Jin; Buslon, Virgil S et al. (2012) The effect of SAMe and betaine on Hepa 1-6, C34 and E47 liver cell survival in vitro. Exp Mol Pathol 92:126-30
French, S W; Bardag-Gorce, F; French, B A et al. (2011) The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model. Exp Mol Pathol 91:653-9
French, B A; Oliva, J; Bardag-Gorce, F et al. (2011) The immunoproteasome in steatohepatitis: its role in Mallory-Denk body formation. Exp Mol Pathol 90:252-6
Bardag-Gorce, Fawzia; French, Samuel W (2011) Delta-aminolevulinic dehydratase is a proteasome interacting protein. Exp Mol Pathol 91:485-9
Qing, Xin; French, Babara A; Oliva, Joan et al. (2011) Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms. Exp Mol Pathol 90:51-4

Showing the most recent 10 out of 68 publications